Chemotherapy of tuberculosis and its challenges.
- Author:
Yu MA
1
Author Information
1. Department of Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China. hongyanenen@163.com
- Publication Type:Journal Article
- MeSH:
Antitubercular Agents;
therapeutic use;
Coinfection;
Humans;
Prevalence;
Public Health;
Tuberculosis;
drug therapy;
epidemiology;
Tuberculosis, Multidrug-Resistant;
drug therapy;
epidemiology
- From:
Acta Academiae Medicinae Sinicae
2009;31(4):389-392
- CountryChina
- Language:Chinese
-
Abstract:
Tuberculosis (TB), a chronic communicable disease, continues to be a global public health concern. Slow decline of TB incidence and prevalence, human immunodeficiency virus/TB coinfection, growth of multidrug-resistant/extensively-resistant TB have made the control of TB even more challenging. Chemotherapy of TB has developed for decades and now also faces similar challenges.
